NYSEAMERICAN:IGC

India Globalization Capital Stock Forecast, Price & News

$1.77

-0.03 (-1.67 %)

(As of 07/30/2021 12:00 AM ET)

Add

Compare

Today's Range

$1.73

▼

$1.82

50-Day Range

$1.10

▼

$2.29

52-Week Range

$0.58

▼

$4.65

Volume1.48 million shs

Average Volume18.27 million shs

Market Capitalization$85.54 million

P/E RatioN/A

Dividend YieldN/A

Beta3.36

30 days | 90 days | 365 days | Advanced Chart

Receive IGC News and Ratings via Email

Sign-up to receive the latest news and ratings for India Globalization Capital and its competitors with MarketBeat's FREE daily newsletter.

About India Globalization Capital

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

India Globalization Capital (NYSEAMERICAN:IGC) Share Price Passes Above 200-Day Moving Average of $0.00
July 31, 2021 | americanbankingnews.com

India Globalization Capital Target of Unusually Large Options Trading (NYSEAMERICAN:IGC)
July 23, 2021 | americanbankingnews.com

Why India Globalization Capital Shares Spiked Today
July 22, 2021 | msn.com

India Globalization Capital Shares Skyrocket On Receiving Patent For THC Formula To Treat Alzheimer's Disease
July 22, 2021 | msn.com

India Globalization Capital Gets U.S. Patent for THC as Alzheimer's Treatment
July 22, 2021 | marketwatch.com

India Globalization Capital Shares Double After Patent for THC
July 22, 2021 | marketwatch.com

IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC
July 22, 2021 | finance.yahoo.com

India Globalization Capital (NYSEAMERICAN:IGC) Stock Price Passes Above Two Hundred Day Moving Average of $0.00
July 21, 2021 | americanbankingnews.com

IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer’s Patients
June 23, 2021 | finance.yahoo.com

IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021
June 14, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Electronic parts & equipment, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:IGC
Previous Symbol
CUSIPN/A
CIK1326205
Webwww.igcinc.us
Phone(301) 983-0998
Employees50
Year FoundedN/A

Sales & Book Value

Annual Sales$900,000.00
Price / Sales95.05
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.72 per share
Price / Book2.46

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares48,330,000
Market Cap$85.54 million
Next Earnings Date8/18/2021 (Estimated)
OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.64 out of 5 stars

Medical Sector

1786th out of 2,222 stocks

Electronic Parts & Equipment, Not Elsewhere Classified Industry

16th out of 24 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for India Globalization Capital.

3.2 Community Rank

Outperform Votes
India Globalization Capital has received 122 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
India Globalization Capital has received 70 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
India Globalization Capital has received 63.54% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about India Globalization Capital and other stocks. Vote “Outperform” if you believe IGC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IGC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
India Globalization Capital does not currently pay a dividend.
Dividend Growth
India Globalization Capital does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, India Globalization Capital insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 12.00% of the stock of India Globalization Capital is held by insiders.
Percentage Held by Institutions
Only 9.21% of the stock of India Globalization Capital is held by institutions.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of India Globalization Capital is -8.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of India Globalization Capital is -8.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
India Globalization Capital has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

India Globalization Capital (NYSEAMERICAN:IGC) Frequently Asked Questions

What stocks does MarketBeat like better than India Globalization Capital?

Wall Street analysts have given India Globalization Capital a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but India Globalization Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting India Globalization Capital?

India Globalization Capital saw a drop in short interest in July. As of July 15th, there was short interest totaling 2,680,000 shares, a drop of 13.5% from the June 30th total of 3,100,000 shares. Based on an average daily trading volume, of 7,320,000 shares, the days-to-cover ratio is presently 0.4 days. Approximately 6.4% of the shares of the company are sold short.
View India Globalization Capital's Short Interest.

When is India Globalization Capital's next earnings date?

India Globalization Capital is scheduled to release its next quarterly earnings announcement on Wednesday, August 18th 2021.
View our earnings forecast for India Globalization Capital.

How were India Globalization Capital's earnings last quarter?

India Globalization Capital, Inc. (NYSEAMERICAN:IGC) issued its quarterly earnings data on Monday, June, 14th. The construction company reported ($0.07) earnings per share for the quarter. The construction company had revenue of $0.08 million for the quarter. India Globalization Capital had a negative trailing twelve-month return on equity of 33.65% and a negative net margin of 981.18%.
View India Globalization Capital's earnings history.

Who are India Globalization Capital's key executives?

India Globalization Capital's management team includes the following people:

Ram Mukunda, President, Chief Executive Officer & Director
Claudia Grimaldi, Principal Financial Officer & Vice President
Jagadeesh Rao, Chief Scientific Officer
Gutierrez de Piñeres, Head-Research
Rohit Goel, Principal Accounting Officer

Who are some of India Globalization Capital's key competitors?

Some companies that are related to India Globalization Capital include VOXX International (VOXX), Orbital Energy Group (OEG), Richardson Electronics (RELL), EACO (EACO), TESSCO Technologies (TESS), Taitron Components (TAIT), Surge Components (SPRS), Simply (SIMP), Universal Security Instruments (UUU), Simply (AWSM), Simply (AWSMD), Bell Industries (BLLI), CLST (CLHI), Enterra (ETER) and Jaco Electronics (JACO).
View all of IGC's competitors.

What other stocks do shareholders of India Globalization Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other India Globalization Capital investors own include GW Pharmaceuticals (GWPH), (CGC), Alibaba Group (BABA), Tilray (TLRY), Cronos Group (CRON), Micron Technology (MU), NewAge (NBEV), Advanced Micro Devices (AMD), Ford Motor (F) and NIO (NIO).

What is India Globalization Capital's stock symbol?

India Globalization Capital trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "IGC."

How do I buy shares of India Globalization Capital?

Shares of IGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is India Globalization Capital's stock price today?

One share of IGC stock can currently be purchased for approximately $1.77.

How much money does India Globalization Capital make?

India Globalization Capital has a market capitalization of $85.54 million and generates $900,000.00 in revenue each year.

How many employees does India Globalization Capital have?

India Globalization Capital employs 50 workers across the globe.

What is India Globalization Capital's official website?

The official website for India Globalization Capital is www.igcinc.us.

Where are India Globalization Capital's headquarters?

India Globalization Capital is headquartered at 4336 Montgomery Ave, BETHESDA, MD 20814-4443, United States.

How can I contact India Globalization Capital?

India Globalization Capital's mailing address is 4336 Montgomery Ave, BETHESDA, MD 20814-4443, United States. The construction company can be reached via phone at (301) 983-0998 or via email at [email protected]

This page was last updated on 7/31/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here